XXI Wealth LLC’s Johnson & Johnson JNJ Stock Holding History

XXI Wealth LLC’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.42M	Sell	13,448 -228	-2%	-$53.1K	1.57%	12
2026 Q1	$3.34M	Buy	13,676 +239	+2%	+$55.7K	1.89%	8
2025 Q4	$2.78M	Buy	+13,437	New	+$2.66M	1.69%	13

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XXI Wealth LLC's JNJ Position: Q2 2026 in Review

XXI Wealth LLC reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $53.1K and leaving 13,448 shares worth $3.42M. The position accounts for 1.57% of the portfolio, ranked #12.

XXI Wealth LLC first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

XXI Wealth LLC held 13,448 shares of Johnson & Johnson worth $3.42M as of Q2 2026.
XXI Wealth LLC sold 228 Johnson & Johnson shares in Q2 2026, an estimated $53.1K.
Johnson & Johnson made up 1.57% of XXI Wealth LLC's portfolio in Q2 2026, its #12 holding.
XXI Wealth LLC first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on XXI Wealth LLC's 13F filing for Q2 2026, filed 14 Aug 2026.